Arrowstreet Capital
INFI

Arrowstreet Capital’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Arrowstreet Capital’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-310,864
Closed -$3.4M – 1533
2015
Q2 		$3.4M Buy
310,864
+197,500
+174% +$2.53M 0.02% 515
2015
Q1 		$1.58M Buy
113,364
+100,817
+804% +$1.54M 0.01% 636
2014
Q4 		$212K Buy
+12,547
New +$183K ﹤0.01% 1182
2013
Q3 		– Sell
-3,665
Closed -$60K – 1146
2013
Q2 		$60K Buy
+3,665
New +$113K ﹤0.01% 794

Other funds holding INFI

ACM
Americafirst Capital Management Roseville, California $74M AUM 30.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital's INFI Position: Q3 2015 in Review

Arrowstreet Capital sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2015, closing a stake of 310,864 shares — an estimated $3.4M sold.

Arrowstreet Capital first reported a position in INFI in Q2 2013 and held it in 4 quarters. The position peaked at $3.4M in Q2 2015. 129 funds tracked by Wall St. Rank hold INFI as of Q3 2015.

  • Arrowstreet Capital reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • Arrowstreet Capital sold 310,864 Infinity Pharmaceuticals, Inc. shares in Q3 2015, an estimated $3.4M.
  • Arrowstreet Capital first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 4 quarters.
  • Arrowstreet Capital's Infinity Pharmaceuticals, Inc. position peaked at $3.4M in Q2 2015.
  • 129 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2015.

Based on Arrowstreet Capital's 13F filing for Q3 2015, filed 5 Nov 2015.